Kidney Stone Removal In Singapore

Procedure duration varies by technique and stone complexity. ESWL typically takes 30-60 minutes of actual treatment time. Ureteroscopy requires 30-90 minutes depending on stone location and size. PCNL procedures usually last 1-3 hours for complete stone removal. These times exclude pre-operative preparation and post-operative recovery. Your urologist will provide a more precise estimate based on your specific stone characteristics during consultation.

Many patients achieve complete stone clearance with a single procedure, particularly for uncomplicated stones. Large stones (>2cm), multiple stones, or hard stone compositions may require staged procedures. ESWL has a 60-90% single-session success rate for appropriate stones, while ureteroscopy and renoscopy exceeds 90% success for most cases. PCNL offers good single-procedure clearance rates for large stones. Your urologist will discuss realistic expectations based on your stone characteristics.

Pain levels vary by procedure and individual tolerance. ESWL causes mild to moderate discomfort during fragment passage, managed with oral pain medications. Ureteroscopy patients experience mild pain, though stent-related discomfort is common until removal. PCNL involves more significant initial discomfort due to the access tract, but this improves rapidly with appropriate pain management. Most patients find the post-procedure discomfort far preferable to kidney stone pain. Your medical team will ensure adequate pain control throughout recovery.

Recovery timelines depend on the procedure performed. ESWL patients typically resume normal activities within 1-2 days, avoiding strenuous exercise for one week. Ureteroscopy allows return to work in 2-5 days, with full activities after stent removal. PCNL requires more recovery time—light activities after one week and complete recovery in 2-4 weeks. Driving is permitted once you’re off strong pain medications and comfortable. Your urologist will provide specific guidelines based on your procedure and occupation.

The risk of recurrence is up to 50% within the first 10 years. Therefore, preventive strategies are an important part of Dr Azhari’s comprehensive kidney stone treatment program.
These depend on stone composition revealed through chemical analysis of the stone removed from patient. General measures include maintaining high fluid intake (2.5-3 litres daily), reducing sodium or salt intake, and moderating animal protein consumption. Specific dietary modifications target different stone types—calcium oxalate stones may require oxalate restriction, while uric acid stones benefit from restricting purine intake and urinary alkalinisation. Some patients need preventive medications. Metabolic evaluation identifies correctable risk factors. Regular follow-up ensures early detection and treatment of recurrent stones.

Stone size influences treatment decisions. Stones smaller than 5mm have a 90% chance of spontaneous passage with medical management. Stones 5-10mm have variable passage rates depending on location—50% for mid-ureter stones versus 10% for upper ureter stones. Stones larger than 10mm rarely pass spontaneously and typically require intervention. Size alone doesn’t determine treatment need—symptoms, stone location, kidney function, and patient factors all influence the decision. Dr Azhari will recommend the optimal treatment based on comprehensive assessment of the patient’s condition.

Several conservative options exist for appropriate cases. Medical expulsive therapy using alpha-blockers may facilitate passage of small stones in the ureter. Dissolution therapy works for specific stone types like uric acid stones. Watchful waiting suits asymptomatic small stones in non-critical locations. These approaches aren’t suitable for large stones, obstructing stones, or those causing complications. Some patients try alternative therapies, though scientific evidence is limited. Dr Azhari will discuss all appropriate options, explaining why surgical removal may be necessary for your situation.